热门资讯> 正文
Iterum Therapeutics第三季度盈利预览
2025-11-13 23:46
- Iterum Therapeutics (ITRM) is scheduled to announce Q3 earnings results on Friday, November 14th, before market open.
- The consensus EPS Estimate is -$0.09 (+62.5% Y/Y)Over the last 2 years, ITRM has beaten EPS estimates 25% of the time and has beaten revenue estimates 0% of the time.
More on Iterum Therapeutics
- Seeking Alpha’s Quant Rating on Iterum Therapeutics
- Historical earnings data for Iterum Therapeutics
- Financial information for Iterum Therapeutics
风险及免责提示:以上内容仅代表作者的个人立场和观点,不代表华盛的任何立场,华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前,应结合自身情况,考虑投资产品的风险。必要时,请咨询专业投资顾问的意见。华盛不提供任何投资建议,对此亦不做任何承诺和保证。